slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 56,371-56,400
Pages 3,679
Rows per page 30
Component
56,371-56,400 of 110,355
13
The slide uses a blue box to visually emphasize the years 2021-2023 having zero debt maturities.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Beat · Visualization1 hit
15
Includes detailed footnotes regarding non-GAAP adjustments and specific expense categories.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
18
Includes a bar chart showing quarterly organic growth from 1Q16 to 4Q20, highlighting a pre-COVID growth period and a post-COVID recovery.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
21
The slide uses a three-part structure to validate the product launch: market size, global reach, and customer satisfaction.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
22
Includes a visual callout for 'Strong Growth Pre-COVID' and 'Recovery in Progress'.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
23
The slide uses trend lines to indicate recovery trajectories for three key pharmaceutical products.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
24
The slide also includes a specific callout regarding Trulance NRx market share growth from March 2019 to December 2020.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
25
Includes a bar chart showing quarterly organic growth trends and text summaries of product-specific performance.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
26
The slide uses a mix of bar charts for market share and line charts for prescription trends to demonstrate recovery.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
28
Includes a list of key growth drivers and a visual grid of brand logos.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
29
The slide uses a timeline-like structure to present upcoming clinical trial milestones and recent COVID-19 treatment developments.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
32
The diagram shows a process flow starting from operational improvements (EBITDA, working capital, delever) leading to three distinct strategic paths.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
34
The slide uses specific financial growth targets to set expectations for the 2019-2022 period.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
37
The table tracks financial performance variances across six business segments.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
38
LOE stands for Loss of Exclusivity. The table highlights the financial decline associated with these events.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
40
The table tracks inventory changes across two periods (4Q19 and 4Q20) for four specific business units.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
41
The table tracks inventory levels for Bausch Health business units.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
42
The slide highlights a 0% organic revenue change for the segment.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
43
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
44
Includes non-GAAP metrics and organic growth calculations.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
45
Includes a callout box highlighting a 6% growth in WELLBUTRIN/APLENZIN revenue.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
47
The slide includes a specific callout for the 6% organic revenue decline and provides context on product-level performance (XIFAXAN and APRISO).Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
48
Includes non-GAAP metrics like EBITA and organic growth; highlights LOE revenue drag.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
49
Includes specific commentary on product-level revenue drivers and LOE impacts.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
51
Includes footnotes regarding non-GAAP information and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
52
The table provides a comparative view of product performance over time.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
54
The table provides a comparative view of product performance over time.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
55
The table highlights FY20 and FY19 data in blue columns.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
56
Data represents U.S. only sales.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
58
The table provides a detailed breakdown of financial metrics for the segment, including non-GAAP adjustments.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit